India’s drug regulatory body, the Central Drugs Standard Control Organisation (CDSCO), approves generic medications based on stringent quality standards, mirroring the processes used for brand-name drugs. This ensures comparable efficacy and safety.
Generic drugs must meet the same bioequivalence standards as their brand-name counterparts. Bioequivalence studies demonstrate that the generic drug releases the active pharmaceutical ingredient into the bloodstream at a comparable rate and extent to the originator product. This data underpins CDSCO approval.
The Indian patent laws allow for the manufacturing and sale of generic drugs after the expiry of the original patent for the brand-name drug. This fosters competition and significantly reduces medication costs, making treatment more accessible.
Before purchasing medications from Indian pharmacies, verify the license and registration of the pharmacy and supplier with the CDSCO. Confirm the manufacturer’s compliance with Good Manufacturing Practices (GMP) guidelines.
Always consult your doctor before using any medication, including generic drugs sourced from India. Discuss potential side effects and interactions with other medications you are taking.
While Indian generic medications offer substantial cost savings, be aware of potential risks associated with purchasing drugs online without verifying the supplier’s authenticity. Legitimate pharmacies will provide clear information about their licensing and contact details.
